Peifasyn Pharmaceutical Coop Of Piraeus
Peifasyn Pharmaceutical Coop Of Piraeus is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 2 of 2 trials · Latest update first
A randomized, double-blind, multicenter, Phase 3 study to evaluate efficacy and safety of belumosudil in combination with corticosteroids versus placebo in combination with corticosteroids in participants at least 12 years of age with newly diagnosed chronic graft versus host disease (cGVHD)
Sponsor Sanofi-Aventis Research & Development
- Start (EU)
- Latest update
- Estimated end
A Phase 2 Randomized, Double-blind, Placebo-controlled, Dose-ranging, Efficacy and Safety study of SAR441566 plus Methotrexate in Adults with Moderate to Severe Rheumatoid Arthritis
Sponsor Sanofi-Aventis Recherche & Developpement
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Peifasyn Pharmaceutical Coop Of Piraeus?
The 2026-10-09 snapshot links Peifasyn Pharmaceutical Coop Of Piraeus to 2 distinct CTIS trials. Recorded services include Medicinal product management. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Peifasyn Pharmaceutical Coop Of Piraeus?
The most frequently recorded therapeutic areas are Immunology, Transplantation. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Peifasyn Pharmaceutical Coop Of Piraeus conducted?
The linked trials record locations in 14 countries, including Czechia, Germany, Spain, Greece, Poland. These are trial locations, not confirmed office locations or countries where Peifasyn Pharmaceutical Coop Of Piraeus delivered services.
What can this page tell me about Peifasyn Pharmaceutical Coop Of Piraeus's trial experience?
Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Peifasyn Pharmaceutical Coop Of Piraeus. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Peifasyn Pharmaceutical Coop Of Piraeus Ltd.